A. Bierhaus, S. Schiekofer, M. Schwaninger, M. Andrassy, P. M. Humpert et al., Diabetes-associated sustained activation of the transcription factor nuclear, 2001.

, The Authors, Physiological Reports published by Wiley Periodicals, Inc. on behalf of The Physiological Society and the American Physiological Society. factor-B. Diabetes, vol.50, pp.2792-2808, 2017.

L. G. Bucciarelli, M. Kaneko, R. Ananthakrishnan, E. Harja, L. K. Lee et al., Receptor for advancedglycation end products: key modulator of myocardial ischemic injury, Circulation, vol.113, pp.1226-1234, 2006.

S. E. Capes, D. Hunt, K. Malmberg, and H. C. Gerstein, Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview, Lancet, vol.355, issue.99, pp.8415-8424, 2000.

G. Delpierre and E. Van-schaftingen, Fructosamine 3-kinase, an enzyme involved in protein deglycation, Biochem. Soc. Trans, vol.31, pp.1354-1357, 2003.

D. Deluyker, V. Ferferieva, J. P. Noben, Q. Swennen, A. Bronckaers et al., Cross-linking versus RAGE: how do high molecular weight advanced glycation products induce cardiac dysfunction?, Int. J. Cardiol, vol.210, pp.100-108, 2016.

, The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin-dependent diabetes mellitus, N. Engl. J. Med, vol.329, pp.977-986, 1993.

M. F. Essop, AGEing heart valves: a bittersweet stiffening process?, J. Clin. Pathol, vol.69, pp.747-749, 2016.

F. Folli, D. Corradi, P. Fanti, A. Davalli, A. Paez et al., The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro-and macrovascular complications: avenues for a mechanistic-based therapeutic approach, Curr. Diabetes Rev, vol.7, pp.313-324, 2011.

G. L. Francis, Albumin and mammalian cell culture: implications for biotechnology applications, Cytotechnology, vol.62, pp.1-16, 2010.

A. Gardner, The benefits of tight glycemic control in critical illness: sweeter than assumed?, Indian J. Crit. Care Med, vol.18, p.807, 2014.

A. Guerin-dubourg, A. Catan, E. Bourdon, and P. Rondeau, Structural modifications of human albumin in diabetes, Diabetes Metab, vol.38, pp.171-178, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01583058

R. N. Johnson, P. A. Metcalf, and J. R. Baker, Fructosamine: a new approach to the estimation of serum glycosylprotein. An index of diabetic control, Clin. Chim. Acta, vol.127, pp.87-95, 1983.

W. B. Kannel, M. Hjortland, and W. P. Castelli, Role of diabetes in congestive heart failure: the Framingham study, AmJ Cardiol, vol.34, p.29, 1974.

S. Li, V. Sigmon, S. Babcock, and J. Ren, Advanced glycation endproduct induces ROS accumulation, apoptosis, MAP kinase activation and nuclear O-GlcNAcylation in human cardiac myocytes, Life Sci, vol.80, pp.1051-1056, 2007.

P. V. Luoma, S. , K. Sikkil?-a, and J. Hassi, High serum alpha-tocopherol, albumin, selenium and cholesterol, and low mortality from coronary heart disease in northern Finland, J. Intern. Med, vol.237, pp.49-54, 1995.

R. F. Mapanga and M. F. Essop, Damaging effects of hyperglycemia on cardiovascular function: spotlight on glucose metabolic pathways, Am. J. Physiol. Heart Circ. Physiol, vol.310, pp.153-173, 2016.

R. Mapanga, U. Rajamani, N. Dlamini, M. Zunguedmondson, R. Kelly-laubscher et al., Oleanolic Acid: a novel cardioprotective agent that blunts hyperglycemia-induced contractile dysfunction, PLoS ONE, vol.7, p.47322, 2012.
URL : https://hal.archives-ouvertes.fr/hal-01198329

R. F. Mapanga, D. Joseph, B. Symington, K. Garson, C. Kimar et al., Detrimental effects of acute hyperglycaemia on the rat heart, Acta Physiol. (Oxf), vol.210, pp.546-564, 2014.

M. L. Marcovecchio, M. Lucantoni, and F. Chiarelli, Role of chronic and acute hyperglycemia in the development of diabetes complications, Diabetes Technol. Ther, vol.13, pp.389-394, 2011.

R. Marfella, C. D. Filippo, M. Portoghese, F. Ferraraccio, M. R. Rizzo et al., Tight glycemic control reduces heart inflammation and remodeling during acute myocardial infarction in hyperglycemic patients, J. Am. Coll. Cardiol, vol.53, pp.1425-1436, 2009.

I. Mart-in-tim-on, C. Sevillano-collantes, A. Segura-galindo, and F. J. , Type 2 diabetes and cardiovascular disease : have all risk factors the same strength?, World J. Diabetes, vol.5, pp.444-470, 2014.

J. C. Mbanya, A. A. Motala, E. Sobngwi, F. K. Assah, and S. T. Enoru, Diabetes in sub-Saharan Africa, Lancet, vol.375, pp.2254-2266, 2010.

C. Mullarkey, D. Edelstein, and M. Brownlee, Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes, Biochem. Biophys. Res. Commun, vol.173, pp.932-939, 1990.

H. E. Mulnier, H. E. Seaman, V. S. Raleigh, S. S. Soedamahmuthu, H. M. Colhoun et al., Mortality in people with type 2 diabetes in the UK, Diabet. Med, vol.23, pp.516-521, 2006.

M. Neeper, A. Schmidt, J. Brett, S. Yan, F. Wang et al., Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins, J. Biol. Chem, vol.267, pp.14998-15004, 1992.

A. Norhammar, A. Tenerz, G. Nilsson, A. Hamsten, S. Efend-ic et al., Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study, Lancet, vol.359, pp.2140-2144, 2002.

A. Phillips, A. G. Shaper, and P. Whincup, Association between serum albumin and mortality from cardiovascular ª 2017 The Authors, Physiological Reports, vol.5, issue.2, pp.1434-1436, 1989.

A. Robinet, L. Alouane, G. Hoizey, and H. Millart, Advanced-glycation end products (AGEs) derived from glycated albumin suppress early beta1-adrenergic preconditioning, Fundam. Clin. Pharmacol, vol.21, pp.35-43, 2007.

M. Roche, P. Rondeau, N. R. Singh, E. Tarnus, and E. Bourdon, The antioxidant properties of serum albumin, FEBS Lett, vol.582, pp.1783-1787, 2008.
URL : https://hal.archives-ouvertes.fr/hal-01198355

P. Rondeau and E. Bourdon, The glycation of albumin: structural and functional impacts, Biochimie, vol.93, pp.645-658, 2011.
URL : https://hal.archives-ouvertes.fr/hal-01198339

P. Rondeau, G. Navarra, F. Cacciabaudo, M. Leone, E. Bourdon et al., Thermal aggregation of glycated bovine serum albumin, Biochim. Biophys. Acta, vol.1804, pp.789-798, 2010.
URL : https://hal.archives-ouvertes.fr/hal-01198342

G. Sawin and A. F. Shaughnessy, Glucose control in hospitalized patients, Am. Fam. Physician, vol.81, pp.1121-1124, 2010.

D. Sell, A. Lapolla, P. Odetti, J. Fogarty, and V. Monnier, Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM, Diabetes, vol.41, pp.1286-1292, 1992.

I. Sleiman, A. Morandi, T. Sabatini, A. Ranhoff, A. Ricci et al., Hyperglycemia as a predictor of inhospital mortality in elderly patients without diabetes mellitus admitted to a sub-intensive care unit, J. Am. Geriatr. Soc, vol.56, pp.1106-1110, 2008.

S. L. Snyder and P. Z. Sobocinski, An improved 2,4,6-trinitrobenzenesulfonic acid method for the determination of amines, Anal. Biochem, vol.64, pp.90431-90436, 1975.

S. Soedamah-muthu, J. Fuller, H. E. Mulnier, V. S. Raleigh, R. Lawrenson et al., High risk of cardiovascular disease in a cohort study using the general practice research database, Diabetes Care, vol.29, pp.798-804, 2006.

, Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with T2DM (UKPDS 33, Lancet, vol.352, pp.837-845, 1998.

J. A. Watts and P. C. Maiorano, Trace amounts of albumin protect against ischemia and reperfusion injury in isolated rat hearts, J. Mol. Cell. Cardiol, vol.31, pp.1653-1662, 1999.

S. Yan, A. Schmidt, G. Anderson, J. Zhang, J. Brett et al., Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins, J. Biol. Chem, vol.269, pp.9889-9897, 1994.

H. Yonekura, Y. Yamamoto, S. Sakurai, T. Watanabe, and H. Yamamoto, Current perspective roles of the receptor for advanced glycation endproducts in diabetes-induced vascular injury, J. Pharmacol. Sci, vol.311, pp.305-311, 2005.

S. Zieman and D. Kass, Advanced glycation endproduct crosslinking in the cardiovascular system: potential therapeutic target for cardiovascular disease, Drugs, vol.64, pp.459-470, 2004.

, | e13107 Page 10 ª 2017 The Authors, Physiological Reports, vol.5, issue.2